9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells

References

• M.A. Jordan and L. Wilson, Microtubules as a target for anticancer drugs, Nat. Rev. Cancer 4 (2004), pp. 253–265. doi:10.1038/nrc1317.
   PubMed Web of Science ®Google Scholar
• E.K. Rowinsky, The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents, Annu. Rev. Med. 48 (1997), pp. 353–374. doi:10.1146/annurev.med.48.1.353.
   PubMed Web of Science ®Google Scholar
• J. Crown and M. O’Leary, The taxanes: An update, Lancet 355 (2000), pp. 1176–1178. doi:10.1016/S0140-6736(00)02074-2.
   PubMed Web of Science ®Google Scholar
• C. Theiss and K. Meller, Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro, Cell Tissue Res. 299 (2000), pp. 213–224. doi:10.1007/s004419900120.
   PubMed Web of Science ®Google Scholar
• K.S. Topp, K.D. Tanner, and J.D. Levine, Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat, J. Comp. Neurol. 424 (2000), pp. 563–576. doi:10.1002/1096-9861(20000904)424:43.0.CO:2-U.
   PubMed Web of Science ®Google Scholar
• K. Ye, Y. Ke, N. Keshava, J. Shanks, J.A. Kapp, R.R. Tekmal, J. Petros, and H.C. Joshi, Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells, Proc. Natl. Acad. Sci. U.S.A. 95 (1998), pp. 1601–1606. doi:10.1073/pnas.95.4.1601.
   PubMed Web of Science ®Google Scholar
• B. Dahlström, T. Mellstrand, C.G. Löfdahl, and M. Johansson, Pharmacokinetic properties of noscapine, Euro. J. Clin. Pharma. 22 (1982), pp. 535–539. doi:10.1007/BF00609627.
   PubMed Web of Science ®Google Scholar
• M.O. Karlsson, B. Dahlstrom, S.A. Eckernas, M. Johansson, and A.T. Alm, Pharmacokinetics of oral noscapine, Eur. J. Clin. Pharmacol. 39 (1990), pp. 275–279. doi:10.1007/BF00315110.
   PubMed Web of Science ®Google Scholar
• L.N. Jensen, L.L. Christrup, L. Jacobsen, J. Bonde, and H. Bundgaard, Relative bioavailability in man of noscapine administered in lozenges and mixture, Acta Pharm. Nord. 4 (1992), pp. 309–312.
   PubMedGoogle Scholar
• Y. Ke, K. Ye, H.E. Grossniklaus, D.R. Archer, H.C. Joshi, and J.A. Kapp, Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses, Can. Immunol. Immunother. 49 (2000), pp. 217–225. doi:10.1007/s002620000109.
   PubMed Web of Science ®Google Scholar
• J. Zhou, K. Gupta, S. Aggarwal, R. Aneja, R. Chandra, D. Panda, and H.C. Joshi, Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation, Mol. Pharma. 63 (2003), pp. 799–807. doi:10.1124/mol.63.4.799.
   PubMed Web of Science ®Google Scholar
• J.W. Landen, R. Lang, S.J. McMahon, N.M. Rusan, A.M. Yvon, A.W. Adams, M.D. Sorcinelli, R. Campbell, P. Bonaccorsi, J.C. Ansel, D.R. Archer, P. Wadsworth, C.A. Armstrong, and H.C. Joshi, Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma, Can. Res. 62 (2002), pp. 4109–4114.
   PubMed Web of Science ®Google Scholar
• J. Zhou, K. Gupta, J. Yao, K. Ye, D. Panda, P. Giannakakou, and H.C. Joshi, Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine, J. Biol. Chem. 277 (2002), pp. 39777–39785. doi:10.1074/jbc.M203927200.
   PubMed Web of Science ®Google Scholar
• N.K. Manchukonda, B. Sridhar, P.K. Naik, H.C. Joshi, and S. Kantevari, Copper (I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapine, Bio. Med. Chem. Lett. 22 (2012), pp. 2983–2987. doi:10.1016/j.bmcl.2012.02.033.
   PubMed Web of Science ®Google Scholar
• N.K. Manchukonda, P.K. Naik, S. Santoshi, M. Lopus, S. Joseph, and S. Kantevari, Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents, PloS One 8 (2013), pp. e77970. doi:10.1371/journal.pone.0077970.
   PubMed Web of Science ®Google Scholar
• S. Santoshi, P.K. Naik, and H.C. Joshi, Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids, J. Biomol. Scr. 16 (2011), pp. 1047–1058. doi:10.1177/1087057111418654.
   PubMedGoogle Scholar
• M.A. Oliva, A.E. Prota, J. Rodríguez-Salarichs, Y.L. Bennani, J. Jiménez-Barbero, K. Bargsten, Á. Canales, M.O. Steinmetz, and J.F. Díaz, Structural basis of noscapine activation for tubulin binding, J. Med. Chem. 63 (2020), pp. 8495–8501. doi:10.1021/acs.jmedchem.0c00855.
   PubMed Web of Science ®Google Scholar
• H.J. Berendsen, D. van der Spoel, and R. van Drunen, GROMACS: A message-passing parallel molecular dynamics implementation, Comp. Phys. Comm. 91 (1995), pp. 43–56. doi:10.1016/0010-4655(95)00042-E.
   Web of Science ®Google Scholar
• S. Santoshi and P.K. Naik, Molecular insight of isotypes specific β-tubulin interaction of tubulin heterodimer with noscapinoids, J. Comp-Aid. Mol. Des. 28 (2014), pp. 751–763. doi:10.1007/s10822-014-9756-9.
   PubMed Web of Science ®Google Scholar
• I. Ali, A. Haque, K. Saleem, and M.F. Hsieh, Curcumin-I Knoevenagel’s condensates and their Schiff’s bases as anticancer agents: Synthesis, pharmacological and simulation studies, Bio-Org. Med. Chem. 21 (2013), pp. 3808–3820. doi:10.1016/j.bmc.2013.04.018.
   PubMed Web of Science ®Google Scholar
• S.M. Sondhi, S. Arya, R. Rani, N. Kumar, and P. Roy, Synthesis, anti-inflammatory and anticancer activity evaluation of some mono-and bis-Schiff’s bases, Med Chem Res. 21 (2012), pp. 3620–3628. doi:10.1007/s00044-011-9899-3.
   Web of Science ®Google Scholar
• S. Santoshi, N.K. Manchukonda, C. Suri, M. Sharma, B. Sridhar, S. Joseph, M. Lopus, S. Kantevari, I. Baitharu, and P.K. Naik, Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents, J. Comp-Aid. Mol. Des. 29 (2015), pp. 249–270. doi:10.1007/s10822-014-9820-5.
   PubMed Web of Science ®Google Scholar
• P.K. Naik, B.P. Chatterji, S.N. Vangapandu, R. Aneja, R. Chandra, S. Kanteveri, and H.C. Joshi, Rational design, synthesis and biological evaluations of amino-noscapine: A high affinity tubulin-binding noscapinoid, J. Comp-Aid. Mol. Des. 25 (2011), pp. 443–454. doi:10.1016/j.jmgm.2011.03.004.
   PubMed Web of Science ®Google Scholar
• R. Aneja, S.N. Vangapandu, M. Lopus, R. Cha.ndra, D. Panda, and H.C. Joshi, Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma, Mol. Pharm. 69 (2006), pp. 1801–1809. doi:10.1124/mol.105.021899.
   PubMed Web of Science ®Google Scholar
• R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis, and P.S. Shenkin, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem. 47 (2004), pp. 1739–1749. doi:10.1021/jm0306430.
   PubMed Web of Science ®Google Scholar
• T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, and J.L. Banks, Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem. 47 (2004), pp. 1750–1759. doi:10.1021/jm030644s.
   PubMed Web of Science ®Google Scholar
• R. Zhou, R.A. Friesner, A. Ghosh, R.C. Rizzo, W.L. Jorgensen, and R.M. Levy, New linear interaction method for binding affinity calculations using a continuum solvent model, J. Phys. Chem. 105 (2001), pp. 10388–10397. doi:10.1021/jp011480z.
   Web of Science ®Google Scholar
• D.A. Case, R.M. Betz, D.S. Cerutti, T.E. Cheatham III, T.A. Darden, R.E. Duke, T.J. Giese, H. Gohlke, A.W. Goetz, N. Homeyer, S. Izadi, P. Janowski, J. Kaus, A. Kovalenko, T.S. Lee, S. LeGrand, P. Li, C. Lin, T. Luchko, R. Luo, B. Madej, D. Mermelstein, K.M. Merz, G. Monard, H. Nguyen, H.T. Nguyen, I. Omelyan, A. Onufriev, D.R. Roe, A. Roitberg, C. Sagui, C.L. Simmerling, W. Botello-Smith, J. Swails, R.C. Walker, J. Wang, R.M. Wolf, X. Wu, L. Xiao, and P.A. Kollman, Amber 2016, Univ. Cal. San Franc, 2016.
   Google Scholar
• J. Wang, W. Wang, P.A. Kollman, and D.A. Case, Automatic atom type and bond type perception in molecular mechanical calculations, J. Mol. Graph. Model. 25 (2006), pp. 247–260. doi:10.1016/j.jmgm.2005.12.005.
   PubMed Web of Science ®Google Scholar
• A. Jakalian, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comp. Chem. 23 (2002), pp. 1623–1641. doi:10.1002/jcc.10128.
   PubMed Web of Science ®Google Scholar
• W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935. doi:10.1063/1.445869.
   Web of Science ®Google Scholar
• J.P. Ryckaert, G. Ciccotti, and H.J. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n- alkanes, J. Comp. Phys. 23 (1977), pp. 327–341. doi:10.1016/0021-9991(77)90098-5.
   Web of Science ®Google Scholar
• T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N. log (N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:10.1063/1.464397.
   Web of Science ®Google Scholar
• U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995), pp. 8577–8593. doi:10.1063/1.470117.
   Web of Science ®Google Scholar
• P.A. Kollman, I. Massova, C. Reyes, B. Kuhn, S. Huo, L. Chong, M. Lee, T. Lee, Y. Duan, and W. Wang, Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models, Acc. Chem. Res. 33 (2000), pp. 889–897. doi:10.1021/ar000033j.
   PubMed Web of Science ®Google Scholar
• E. Hamel and C.M. Lin, Glutamate-induced polymerization of tubulin: Characteristics of the reaction and application to the large scale purification of tubulin, Arch. Biochem. Biophys. 209 (1981), pp. 29–40. doi:10.1016/0003-9861(81)90253-8.
   PubMed Web of Science ®Google Scholar
• D. Panda, G. Chakrabarti, J. Hudson, K. Pigg, H.P. Miller, L. Wilson, and R.H. Himes, Suppression of microtubule dynamic instability and treadmilling by deuterium oxide, J. Biochem. 39 (2000), pp. 5075–5081. doi:10.1021/bi992217f.
   Google Scholar
• M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976), pp. 248–254. doi:10.1016/0003-2697(76)90527-3.
   PubMed Web of Science ®Google Scholar
• P.K. Naik, M. Lopus, R. Aneja, S.N. Vangapandu, and H.C. Joshi, In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: Folate conjugated noscapine (Targetin), J. Comp-Aid. Mol. Des. 26 (2012), pp. 233–247. doi:10.1007/s10822-011-9508-z.
   PubMed Web of Science ®Google Scholar
• R. Aneja, S.N. Vangapandu, M. Lopus, V.G. Viswesarappa, N. Dhiman, A. Verma, R. Chandra, D. Panda, and H.C. Joshi, Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death, Biochem. Pharm. 72 (2006b), pp. 415–426. doi:10.1016/j.bcp.2006.05.004.
   PubMed Web of Science ®Google Scholar
• N. Jain, D. Yada, T.B. Shaik, G. Vasantha, P.S. Reddy, S.V. Kalivendi, and B. Sreedhar, Synthesis and antitumor evaluation of nitrovinyl biphenyls: Anticancer agents based on allocolchicines, Chem. Med. Chem. 6 (2011), pp. 859–868. doi:10.1002/cmdc.201100019.
   Google Scholar